Alec Machiels - 21 Jul 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Director
Signature: /s/ David Watson, attorney-in-fact for Alec Machiels
Issuer symbol: APLS
Transactions as of: 21 Jul 2023
Net transactions value: +$132,910
Form type: 4
Filing time: 24 Jul 2023, 17:01:36 UTC
Previous filing: 21 Jul 2023
Next filing: 18 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$132,910	+49,779	+16%	$2.67^*	367,420	21 Jul 2023	Direct
holding	APLS	Common Stock						250,000	21 Jul 2023	Indirect Owner (Bauhaus 1 LLC)	F1
holding	APLS	Common Stock						11,950	21 Jul 2023	Indirect Owner (Owned by Spouse)	F2
holding	APLS	Common Stock						150,000	21 Jul 2023	Indirect Owner (Spouse Trust)	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-49,779	-91%	$0.000000	5,000	21 Jul 2023	Common Stock	49,779	$2.67	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
F2	Owned by spouse.
F3	On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
F4	This option was granted on December 5, 2013 and fully vested.